Viewing Study NCT05432466


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-27 @ 6:04 PM
Study NCT ID: NCT05432466
Status: RECRUITING
Last Update Posted: 2025-08-24
First Post: 2022-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Sponsor: Acer Therapeutics Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-11-07
Start Date Type: ACTUAL
Primary Completion Date: 2029-03-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-04-01
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-21
First Submit QC Date: None
Study First Post Date: 2022-06-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-19
Last Update Post Date: 2025-08-24
Last Update Post Date Type: ACTUAL